News: Clinical Trials

Next Page »

VICC’s Johnson to study cancer survivorship with immune inhibitor drugs

Thursday, March 19th, 2015

Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network  (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs called immune checkpoint inhibitors. The formal announcement of the grant awardees was made […]

Mutations may predict melanoma response to immunotherapies

Thursday, March 12th, 2015

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Douglas Johnson, M.D., assistant professor of Medicine, and Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, are co-first authors […]

‘Cancer: The Emperor of All Maladies’

Wednesday, March 11th, 2015

The Vanderbilt-Ingram Cancer Center, in collaboration with Nashville Public Television, American Cancer Society, and Gilda’s Club, will host a free preview of “Cancer: The Emperor of All Maladies,” panel discussion and moderated Q&A on Wednesday, March 25 at the Vanderbilt University Student Life Center.

Exploring myeloma treatment’s impact on heart

Thursday, February 5th, 2015

  Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart. The Prospective Observation of Cardiac Safety with Proteasome Inhibition (PROTECT) trial capitalizes on the collaborative relationship between Vanderbilt Heart and Vascular Institute and Vanderbilt-Ingram Cancer Center, with the goal of managing cardiac toxicity […]

New Method May Allow Personalized Clinical Trial for Cancer Therapies

Tuesday, August 14th, 2012

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy – and may offer a way to further refine personalized cancer treatments. The approach, developed by investigators at Vanderbilt-Ingram Cancer Center, shows that erlotinib – a targeted therapy that acts on a growth factor receptor mutated in […]

Patient Lauded for Clinical Trial Participation

Wednesday, June 13th, 2012

A breast cancer patient who has enrolled in two clinical research trials at Vanderbilt-Ingram Cancer Center was the only presenter to receive a standing ovation during a recent Stand Up To Cancer (SU2C) news briefing at the American Association for Cancer Research (AACR) annual meeting in Chicago. Jeanette Daniel, 51, a metastatic breast cancer patient, […]

Lung Cancer Screening Trial Helps First Patient

Friday, March 2nd, 2012

Kathy Leiser first heard about Vanderbilt-Ingram Cancer Center’s lung cancer screening trial through a sponsorship ad on WPLN radio last summer. The Nashville office technology saleswoman and grandmother of three had stopped smoking in 2009, but she knew her smoking history put her at risk for lung cancer. So she enrolled in the screening trial, […]

Detecting Lung Cancer Early

Monday, November 7th, 2011

Dr. Pierre Massion, associate professor of medicine and cancer biology at Vanderbilt-Ingram Cancer Center, explains why it is difficult to detect lung cancer at an early stage. He also describes the Nashville Lung Cancer Screening Trial and how he hopes the study will establish a better screening process. If you are interested in learning more […]

VUMC Teams with 3 Midstate Hospitals

Friday, September 23rd, 2011

Leaders of Vanderbilt University Medical Center, Maury Regional Medical Center, Northcrest Medical Center and Williamson Medical Center today announced affiliation agreements establishing a partnership between these medical centers to work collaboratively to create new jointly operated programs and services in the counties where these hospitals reside. These programs are intended to expand primary and specialty […]

Cancer Center Debuts Clinic in Green Hills

Friday, August 19th, 2011

Vanderbilt-Ingram Cancer Center has opened a free-standing cancer clinic in Green Hills to give cancer patients more options for their oncology care. VICC Green Hills provides many of the same services available at the main VICC campus, including access to board-certified cancer physicians and specially trained oncology nurses and pharmacists. Patients can see an oncologist, […]